CD40 and cancer: To further explore anti-CD40 mAb therapy for effective cancer treatment, we investigated the potentiating effect of 341G2 hIgG2 on adoptive T cell transfer that has demonstrated clinical efficacy in some difficult-to-treat cancers (Maude et al., 2018, Neelapu et al., 2017).